A Therapeutic Challenge: Management of Atrial Thrombus

Yıl 2016, Cilt: 7 Sayı: 4, 278 - 282, 30.12.2016

Serkan Burç Deşer , Mustafa Kemal Demirağ

https://doi.org/10.5799/jcei.328366

Öz

Introduction: Primary cause of atrial thrombi include atrial fibrillation, foreign bodies inside the atrium such as
catheters and pacemaker leads, emboli of deep venous thrombus and primary or metastatic tumors of the heart. We
review the clinical features, epidemiology, diagnosis and treatment of nine intriguing cases with atrial thrombus.
Methods: This is a retrospective study of nine patients (seven female (78%), two male (33%)) who were diagnosed
with atrial thrombi (average age of 50 ± 12 years) and were treated at the Ondokuz Mayis University, Department of
Cardiovascular Surgery from February 2014 to January 2015. Among them, six patients had atrial fibrillation (one
male, five female), seven patients were suffering from dispne and orthopnoea, five patients were suffering from leg
swelling, seven patients had a history of hypertension and three patients had a history of mitral valve replacement
surgery.
Results: All patients underwent surgery except one. Four patients recovered uneventfully and discharged with oral
anticoagulation (warfarin) therapy (adjusted to maintain an international normalized ratio of INR between two and
three times). Five of nine patients (55%) died after surgery.
Conclusion: The response to the thrombolytic therapy is poor, mostly ineffective and unsafe so it is often
recommended as a bridge to surgery. In patients diagnosed with mechanical mitral valve thrombosis, medical therapy
has the possibility of end organ emboli and also fail to resolve the organised thrombus on the stuck valve. On the
other hand surgery does not always give satisfactory results. J Clin Exp Invest 2016; 7(4): 278-282

Anahtar Kelimeler

Thrombus, atrium, treatment

Kaynakça

• 1. Sheikh A, Schrepfer S, Stein W, et al. Right atrial mass after primary repair of an atrial septal defect: thrombus masquerading as a myxoma. Ann Thorac Surg 2007; 84:1742-1744.
• 2. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002;25:1605-1616.
• 3. Hartier L, Bera J, Delomez M, et al. Free-floating thrombi in right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999;99:2779-2783.
• 4. Barakat K, Robinson MN, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with review of the literature. Cardiology 2000; 93:142-148.
• 5. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002; 121:806-814.
• 6. Blann AD, Lip GY. Lip. Atrial Fibrillation and Thrombosis: The Missing Molecular Links. JACC 2013; 61:861-862.
• 7. Kaskia JC, Arrebola AL. Inflammation and Thrombosis in Atrial Fibrillation. Rev Esp Cardiol 2011; 64 :551-553.
• 8.Nicolaou N, Becker A, Mc Michael G, Nicolaou V. Giant atrial thrombus presenting as a tumor. Int J Surg Case Reports 2013; 4:62-64.
• 9. Natarajan A,Tan S, Patel HN, Chukwu C, Harkness A, Harris S. Mass in the Left Atrial Appendage: A Therapeutic Dilemma. Can J Cardiol 2013; 29(10):1329.e13-1329.e15.
• 10. Yang EH, Moriarty JM, Lluri G, Aboulhosn JA. Giant left atrial appendage mimicking a mediastinal mass in a new diagnosis of atrial septal defect and pulmonic stenosis. Int J Cardiol. 2014; 175 (2):e27–e29.